Duchenne Muscular Dystrophy in Turkey
How patients in Turkey access treatment for duchenne muscular dystrophy via Named Patient Program.
About Duchenne Muscular Dystrophy
Neuromuscular
Treatment access in Turkey
Turkey's TITCK operates a named-patient program; HCPs coordinate with Turkish Pharmacists' Association.
For patients in Turkey with duchenne muscular dystrophy whose required therapy is not locally registered, a Named Patient Program pathway typically applies.
How Reserve Meds supports patients with duchenne muscular dystrophy in Turkey
- Patient or physician contacts us with disease details and therapy requested.
- We verify eligibility in Turkey and confirm US supply.
- Treating physician in Turkey issues prescription and justification.
- We file Turkey-specific NPP/personal-import paperwork.
- We source the drug from a DSCSA-compliant US specialty wholesaler.
- Cold-chain shipment to the patient's physician or hospital pharmacy in Turkey.
Patient support throughout
- Case manager from request through delivery.
- Documentation translation where needed.
- Physician-to-physician support for clinical justification.
- Re-supply coordination for chronic therapy.